Related Experiment Video
Updated: Jun 11, 2025
Author Spotlight: Exploring Cloning Techniques for Full-Length DNA Fragments
Published on: May 17, 2024
Inhibition Effect of STING Agonist SR717 on PRRSV Replication.
Xuanying Si1,2, Xiaoge Wang1,2, Hongju Wu1,2
1National International Joint Research Center for Animal Immunology, School of Animal Medicine, Henan Agricultural University, Zhengzhou 450046, China.
The novel compound SR717 demonstrates significant antiviral activity against porcine reproductive and respiratory syndrome virus (PRRSV). This pyridazine-3-carboxamide compound inhibits PRRSV replication by activating the STING pathway, offering potential as a new therapeutic agent.
Area of Science:
- Virology
- Immunology
- Drug Discovery
Background:
- Porcine reproductive and respiratory syndrome virus (PRRSV) is a significant threat to swine health, caused by an RNA virus.
- Current PRRSV vaccines offer limited long-term protection, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the potential antiviral effects of SR717, a known STING agonist, against PRRSV.
- To elucidate the mechanism of action of SR717 in inhibiting PRRSV infection.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
- Immunofluorescence assay (IFA)
- Western blot (WB)
- Assessment of STING pathway activation and antiviral molecule production.
Main Results:
- SR717 exhibited a dose-dependent inhibition of PRRSV replication across multiple strains.
- SR717 treatment stimulated the production of antiviral molecules.
- Activation of the stimulator of interferon genes (STING) pathway was observed, contributing to viral inhibition.
Conclusions:
- SR717 effectively inhibits PRRSV infection in vitro.
- SR717's mechanism involves STING pathway activation and induction of antiviral responses.
- SR717 shows promise as a potential antiviral drug for PRRSV.
More Related Videos
09:35Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis
Published on: August 9, 2013
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
